3.16
3.16 (0%)
As of Feb 14, 2025
Sana Biotechnology, Inc. [SANA]
Source:
Company Overview
Sana Biotechnology, Inc. is developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology.
Country | United States |
Headquarters | seattle, washington |
Phone Number | (206) 701-7914 |
Industry | manufacturing |
CEO | Steven D. Harr, M.D. |
Website | www.sana.com |